Director · Xeris Biopharma Holdings, Inc. · Common Stock
Side
SELL
Value
$60K
Shares
10.8K
Price
$5.54
Executed
Mar 30, 2026
Disclosed
Apr 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 30 executedApr 1, 2026 disclosed
XERS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Brady James Aloysius filed this Form 4 reporting a open-market sale of XERS on Mar 30, 2026. It became public on Apr 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Brady James Aloysiuscik:0001916987
Issuer
Xeris Biopharma Holdings, Inc.cik:0001867096
Revision history · 0
No field has changed since this record was first ingested.
